Milana Jarakovic

Dr. Milana Jarakovic

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
PDF file
MJMilana Jarakovic
Milana Jarakovic
MPMilovan Petrovic
Milovan Petrovic
DIDragan Ivanisevic
Dragan Ivanisevic
BMBojan Mihajlovic
Bojan Mihajlovic
MKMila Kovacevic
Mila Kovacevic
IPIva Popov
Iva Popov
Introduction/Objective. The optimal percutaneous coronary intervention (PCI) in patients with non-STelevated myocardial infarction (NSTEMI) and multivessel coronary artery disease (CAD) is still not clear. The aim of our study was to examine intrahospital and long-term major adverse cardiovascular and cerebrovascular events (MACCE) in this group of patients. Methods. This retrospective study included 225 patients with NSTEMI and multivessel CAD treated with PCI at the Institute of Cardiovascular Diseases of Vojvodina. Three groups were formed: complete one-stage PCI; complete multi-stage PCI, and culprit-only PCI. We analyzed intrahospital and one-year follow-up MACCE and mortality after three years in all three groups. Results. Complete one-stage PCI was performed in 112 (49.8%), complete multi-stage PCI in 70 (31.3%), and culprit-only PCI in 43 (19.1%) patients. Patients with multi-stage complete PCI had the lowest mortality in comparison with one-stage and culprit-only PCI, both intrahospital (0% vs. 0.9% and 20.9%, respectively, p < 0.0005) and after one year (0% vs. 2.7% and 30.2%, respectively, p < 0.0005) and three years (4.3% vs. 5.4% and 32.6%, respectively, p < 0.0005). There was no significant difference in other MACCE between the groups, both intrahospital and after one year. Conclusion. In our study, multi-stage PCI significantly reduces intrahospital, one-year and three-year follow-up mortality in patients with NSTEMI and multivessel CAD.

20 August 2025 in COVID
Verified
Journal Article
Open access
PDF file
Andrej PrevedenAndrej Preveden
Andrej Preveden
Marina BandulajaMarina Bandulaja
Marina Bandulaja
VTVanja Drljevic Todic
Vanja Drljevic Todic
RZRanko Zdravkovic
Ranko Zdravkovic
MGMiodrag Golubovic
Miodrag Golubovic
MPMihaela Preveden
Mihaela Preveden
Background: The lockdown and other measures for coronavirus disease 2019 (COVID-19) prevention have presented an enormous burden on healthcare systems, causing reorganization in work and lowering the number of elective hospitalizations, along with a consequent reduction in hospital-acquired infections and bacteremia. The aim of this study was to examine the influence of the COVID-19 pandemic on the diagnosis and management of infective endocarditis (IE). Methods: The study included 111 patients admitted for IE from 1 January 2017 to 31 December 2021. They were divided in two groups chronologically according to the COVID-19 pandemic: the first group consisted of patients before the pandemic (n = 85), while the second group consisted of patients during the pandemic (n = 26). Results: Before the pandemic there were 2.26 ± 1.41 cases/month with diagnosis of IE, while during the pandemic there were only 1.14 ± 1.15 cases/month (p = 0.004). IE patients during the pandemic were younger (53 [41–65] vs. 68 [52–74] years; p < 0.05). A similar number of patients underwent surgical treatment before and during COVID-19 (53% vs. 67%; p = 0.210) and 30-day mortality was comparable (28% vs. 22%; p = 0.539). Conclusion: The COVID-19 pandemic and lockdown measures have led to a reduction in the number of patients with IE, although this change did not influence management strategies and mortality.

1 January 2022 in Medicinski Pregled
Verified
Journal Article
Open access
PDF file
BMBojan B. Mihajlović
Bojan B. Mihajlović
ARAleksandar Redzek
Aleksandar Redzek
MJMilana Jarakovic
Milana Jarakovic
TPTanja Popov
Tanja Popov
DADejan Aleksandric
Dejan Aleksandric
Lazar VelickiLazar Velicki
Lazar Velicki
Introduction. The aim of this study was to evaluate the predictive value of the European System for Cardiac Operative Risk Evaluation II in adult patients with acquired heart diseases. Material and Methods. The research included a consecutive series of 6,031 patients who underwent coronary, valvular and combined cardiac surgical interventions in the period from January 15, 2015 to December 31, 2020. Model calibration was assessed by comparing the ratio of actual to expected postoperative mortality and using the Hosmer-Lemeshow test. The discriminative power was examined using the area under the receiver operating characteristic curve. Results. A total of 2,883 patients underwent isolated coronary surgery, 1,841 underwent valvular procedures, while a combined procedure was performed in 1,307 patients. The operative risk was moderately underestimated in the entire group, as well as in the group of patients who underwent surgical revascularization of the coronary arteries. In patients who underwent valvular surgery, the actual mortality rate was slightly overestimated, while in patients with combined procedures it was moderately underestimated. The European System for Cardiac Operative Risk Evaluation II showed excellent discriminative power in the whole group of patients undergoing surgery (area under the curve = 0.825, p < 0.0005). The cut-off value was 2.60, sensitivity 0.757 and specificity 0.750. The discriminative power of the model was excellent in the group of coronary patients (area under the curve = 0.810) as well as in the group with isolated valvular surgery (area under the curve = 0.815). In patients with combined procedures, the discriminatory power was very good (area under the curve = 0.775). Conclusion. The results of our single centre study show that European System for Cardiac Operative Risk Evaluation II predicts hospital mortality with satisfactory results in the entire group, but underestimates it when it comes to combined cardiac surgical procedures. The discriminative power of the model is excellent.

20 January 2026 in Diseases
Verified
Journal Article
Open access
PDF file
AIAnastasija Ilić
Anastasija Ilić
OKOlivera Kovačević
Olivera Kovačević
AMAleksandra Milovancev
Aleksandra Milovancev
Nikola MladenovicNikola Mladenovic
Nikola Mladenovic
DADragica Andrić
Dragica Andrić
Andrej PrevedenAndrej Preveden
Andrej Preveden
Objective: The aim of this study was to evaluate the impact of chronic kidney disease (CKD) on clinical presentation, laboratory parameters, ECG, and echocardiographic features of patients with chronic heart failure (CHF). Methods: This retrospective cross-sectional study included 2227 patients hospitalized in a tertiary care center due to CHF. Patients were divided into two groups based on the presence of CKD, defined as eGFR < 60 mL/min/1.73 m2. Demographic, clinical, laboratory, and echocardiographic data were collected for all patients. Comparative analyses were performed to assess differences in cardiovascular risk factors, comorbidities, laboratory parameters, and echocardiographic findings between the two groups. Results: The proportion of men was significantly higher in the non-CKD group, whereas women predominated in the CKD group (p < 0.001). Dyspnea, orthopnea, leg swelling, claudication, and expectoration were significantly more frequent in patients with CKD, while chest pain and palpitations were more common in the non-CKD group (all p < 0.05). A significant difference in the distribution of NYHA functional classes was observed between the groups (p < 0.001), with NYHA class IV being more prevalent in the CKD group and classes II and III more frequent in the non-CKD group. Levels of CRP and NT-proBNP were significantly higher in the CKD group (p < 0.001). In-hospital mortality was 2.5-fold higher in patients with CKD (28.6% vs. 11.1%; p < 0.001). Conclusions: Coexistence of CKD was associated with a more severe clinical presentation, advanced functional limitation, and a distinct laboratory and echocardiographic profile in CHF patients.

1 January 2022 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
PDF file
BMBojan Mihajlovic
Bojan Mihajlovic
ARAleksandar Redzek
Aleksandar Redzek
Lazar VelickiLazar Velicki
Lazar Velicki
MJMilana Jarakovic
Milana Jarakovic
DBDragic Bankovic
Dragic Bankovic
BMBogoljub Mihajlovic
Bogoljub Mihajlovic
Introduction/Objective The Risk factors in coronary patients indicated for surgery change during the years. The aim of this study was to analyze the trends of risk factors which enter into the composition of the European System for Cardiac Operative Risk Evaluation (EuroSCORE II). Methods The research included 3996 patients who underwent coronary surgery from January 2012 to December 2020 at our clinic. For estimation of the risk factors and evaluation of the operative risk, the EuroSCORE II model was used. Kruskal-Wallis H test was used for testing differences of values of numerical variables between years. The calibration and the discriminative power of the EuroSCORE II were assesed by comparing the observed to the expected mortality ratio and by using area under the receiver operating characteristic curve (AUC). Results The old age has shown a significant increasing trend (p < 0.0005), as well as diabetes mellitus on insulin therapy, before surgery (p = 0.004). The significant declining trend have shown: extracardiac arteriopathy (p = 0.003), critical preoperative condition (p = 0.013), preoperative NYHA Classes III or IV (p < 0.0005) and preoperative angina pectoris CCS Class IV (p < 0.0005). The mean value of the EuroSCORE II decreased from 1.73 to 1.53 (p < 0.0005). The observed mortality was 1.70% and the mean, predicted by the EuroSCORE II, was 1.75%. The O/E mortality ratio was 0.98; 95% confidence interval 0.95-1.03. The AUC was 0.825. Conclusion Over the past decade the risk profile of patients for coronary surgery has changed. The mean value of the EuroSCORE II has declining trend with a good predictive and discriminative power.

1 January 2023 in Srce i krvni sudovi
Verified
Journal Article
Open access
PDF file
MVMarija Vesić
Marija Vesić
IPIvan Petrović
Ivan Petrović
IMIsidora Milosavljević
Isidora Milosavljević
DDDragana Dabović
Dragana Dabović
BCBranislav Crnomarković
Branislav Crnomarković
MCMilenko Cankovic
Milenko Cankovic
Introduction. There is limited information available regarding the quality of life (QoL) in patients with Peripartum Cardiomyopathy (PPCM). We assessed how the disease impacted the day-to-day functioning of respondents, who were concerned about their QoL in the two weeks preceding the survey. Methods. The study involved 24 subjects treated at the Institute for Cardiovascular Diseases of Vojvodina from January 2006 to December 2019. The Kansas City Cardiomyopathy Questionnaire (KCCQ) was used to assess their quality of life. The collected data were statistically processed. Results. The mean age of the subjects was 37 ± 6.4 years, with an average time since initial diagnosis of 5.9 ± 3.4 years. Out of 24, thirteen participants completed the questionnaire, and a majority of respondents (53.8%) reported feeling sad or discouraged due to the effects of heart failure on their lives. Only 30.8% of respondents expressed complete satisfaction with the idea of living at their current level due to heart failure. Fatigue and weakness were reported by 76.9% of female participants. The initial left ventricle ejection fraction (EFLV) was predominantly severely impaired, while the currently measured EFLV averaged 55±10%. At follow-up, 38.4% showed no symptoms of heart failure. A majority (76.9%) were unable to engage in high-intensity physical activities. Conclusion. Although most patients experience cardiac muscle recovery after the acute phase of PPCM, the disease continues to have long-term effects on their quality of life and mental well-being.